Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine. SARASOTA, Fla, Oct. 16, 2022 /PRNewswire/ — Spectrum Dynamics today announced its newest development in digital nuclear medicine imaging: the capability to […]
Other News
New Initiative to Prevent, Treat and Beat Stroke Focuses on Health Equity, Heart-brain Connection
The American Heart Association’s Getting to the Heart of Stroke™ initiative, developed in conjunction with and supported by HCA Healthcare and the HCA Healthcare Foundation, focuses on preventing, treating and beating stroke by providing consumer and health care professional education nationwide, deepening collaboration between neurology and cardiology and equitably empowering communities […]
Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery
Dr. Johnston will serve as chief of cardiac surgery and surgical director of Bluhm Cardiovascular Institute CHICAGO, Oct. 13, 2022 /PRNewswire/ — Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School […]
Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
The HELIOSTAR™ Balloon Ablation Catheter’s unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution1 IRVINE, Calif., Oct. 13, 2022 /PRNewswire/ — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation […]
Fountain Life Appoints Rakesh M. Suri, M.D., D.Phil., as President and Chief Medical Officer
Prominent Cardiac Surgeon and Former Cleveland Clinic Leader to Drive Global Growth of Preventative Health Company NAPLES, Fla., Oct. 13, 2022 /PRNewswire/ — Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Rakesh M. Suri, M.D., D.Phil., as the company’s […]
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic System, the first disposable robotic system being developed for endovascular procedures. The study was performed by a team of seasoned Key […]
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
DANVERS, Mass.–(BUSINESS WIRE)–An analysis of more than 2,000 patients from a large U.S. real-world database finds that patients who underwent a non-emergent high-risk PCI with the Impella heart pump (n=1,447) had significantly improved survival, reduced myocardial infarction, reduced cardiogenic shock after PCI and shorter length of stay than matched patients treated with […]
Treatment of Severe Heart Failure – AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER® First-In-Human Trials
ICOMS FLOWMAKER®, First Fully Implantable Electro-Physiological Cardiac Assistance Device Guillaume Buc, Chief Technical Officer Sophie Jonquière, Chief Procurement & Supply Chain Officer BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet […]
CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
PRINCETON, N.J., Oct. 12, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the presentation of exciting new data on the use of CytoSorb® in various cardiac surgery indications at the […]
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
Senior team enhanced to advance Aziyo’s commercial and financial objectives SILVER SPRING, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a biological device company with a portfolio of commercial products across four distinct businesses, today announced key promotions and new hires that solidify its position as […]



